GCC Oncology/Cancer Drugs Market Growth and Challenges

GCC Oncology/Cancer Drugs Market Research Report: Forecast (2023-2028)

By Therapy (Chemotherapy, Immunotherapy, Targeted Therapy, Hormonal Therapy, Others), By Application Breast Cancer, (Lung Cancer, Kidney Cancer, Liver cancer, Ovarian Cancer, Prostate Cancer, Skin Can... ... ate Cancer, Skin Cancer, Pancreatic Cancer, Colorectal, Blood Cancer, Others), By Country (Saudi Arabia, The UAE, Qatar, Kuwait, Bahrain, Oman), By Company (Hoffmann-La Roche Ltd., Johnson & Johnson Middle East FZ LLC, Pfizer International Corporation, Merck Serono Middle East FZ-Ltd., AbbVie Biopharmaceuticals GmbH, AstraZeneca Gulf FZ LLC, Bayer Middle East FZE, Amgen, Inc., Astellas MENA/SSA, Others) Read more

Healthcare
Mar 2023
Pages 187
Report Format: PDF, Excel, PPT

Market Definition

Oncology drugs are therapeutics used to treat cancer, a group of diseases caused by uncontrolled growth and division of abnormal cells. Oncology drugs include a range of different types of medications, such as chemotherapy agents, targeted therapies, immunotherapies, and hormone therapies.

Market Insights & Analysis: GCC Oncology/Cancer Drugs Market (2023-28)

The GCC Oncology/Cancer Drugs Market is projected to grow at a considerable CAGR during the forecast period, i.e., 2023-28. This is due to the rising incidences of patients diagnosed with cancer in the nations like the UAE, Saudi Arabia, Kuwait, etc., and the surging initiative to reduce the number of deaths due to cancer. As per the World Health Organization, a total of around 21.4% of breast cancer cases were reported in 2020 in the UAE, whereas the same around 14.5% of colorectal cancer, and nearly 12.5% of prostate cancer were reported among men in the country.

Report Coverage	Details
Study Period	Historical Data: 2018-21
	Base Year: 2022
	Forecast Period: 2023-28
Country Covered	Saudi Arabia, The UAE, Qatar, Kuwait, Bahrain, Oman
Key Companies Profiled	Hoffmann-La Roche Ltd., Johnson & Johnson Middle East FZ LLC, Pfizer International Corporation, Merck Serono Middle East FZ-Ltd., AbbVie Biopharmaceuticals GmbH, AstraZeneca Gulf FZ LLC, Bayer Middle East FZE, Amgen, Inc., Astellas MENA/SSA, Others
Unit Denominations	USD Million/Billion

In addition to this, Saudi Arabia also registered around 14.4% of colorectal cancer cases among the population in 2020, according to the World Health Organization. Therefore, the rising prevalence of several types of cancer cases among the men and women population of the GCC nations is estimated to create the potential demand for oncology/cancer drugs in the forecast years, thereby creating a positive market outlook for the growth of the GCC Oncology/Cancer Drugs market from 2023 to 2028.

In line with this, the surging investments by the governments in the region to support and enhance the healthcare facilities of the hospitals, clinics, etc., are resulting in a significant demand for a variety of oncology/cancer drugs. Also, the uprising healthcare infrastructure developments in the countries like the UAE, Saudi Arabia, etc., would necessitate the demand for these treatment drugs in the forecast years, further enhancing the GCC Oncology/Cancer Drugs Market size. For instance:

In 2023, the government of Saudi Arabia Announced to invest around USD65 billion to develop the country’s healthcare infrastructure.

Market Segmentation
Introduction
1. Product Definition
2. Research Process
3. Assumptions
Executive Summary
GCC Oncology/Cancer Drugs Market Trends & Insights
GCC Oncology/Cancer Drugs Market Dynamics
1. Drivers
2. Challenges
GCC Oncology/Cancer Drugs Market Regulations & Policies
GCC Oncology/Cancer Drugs Market Hotspots & Opportunities
GCC Oncology/Cancer Drugs Market Outlook, 2018-2028F
1. Market Size & Analysis
  1. By Revenues (USD Million)
2. Market Share & Analysis
  1. By Therapy
    1. Chemotherapy
    2. Immunotherapy
    3. Targeted Therapy
    4. Hormonal Therapy
    5. Others
  2. By Application
    1. Breast Cancer
    2. Lung Cancer
    3. Kidney Cancer
    4. Liver cancer
    5. Ovarian Cancer
    6. Prostate Cancer
    7. Skin Cancer
    8. Pancreatic Cancer
    9. Colorectal
    10. Blood Cancer
    11. Others
  3. By Country
    1. Saudi Arabia
    2. The UAE
    3. Qatar
    4. Kuwait
    5. Bahrain
    6. Oman
  4. By Company
    1. Competition Characteristics
    2. Market Share of Leading Companies, By Revenues
Saudi Arabia Oncology/Cancer Drugs Market Outlook, 2018-2028F
1. Market Size & Analysis
  1. By Revenues (USD Million)
2. Market Share & Analysis
  1. By Therapy
  2. By Application
The UAE Oncology/Cancer Drugs Market Outlook, 2018-2028F
1. Market Size & Analysis
  1. By Revenues (USD Million)
2. Market Share & Analysis
  1. By Therapy
  2. By Application
Qatar Oncology/Cancer Drugs Market Outlook, 2018-2028F
1. Market Size & Analysis
  1. By Revenues (USD Million)
2. Market Share & Analysis
  1. By Therapy
  2. By Application
Kuwait Oncology/Cancer Drugs Market Outlook, 2018-2028F
1. Market Size & Analysis
  1. By Revenues (USD Million)
2. Market Share & Analysis
  1. By Therapy
  2. By Application
Bahrain Oncology/Cancer Drugs Market Outlook, 2018-2028F
1. Market Size & Analysis
  1. By Revenues (USD Million)
2. Market Share & Analysis
  1. By Therapy
  2. By Application
Oman Oncology/Cancer Drugs Market Outlook, 2018-2028F
1. Market Size & Analysis
2. Market Size & Analysis
  1. By Revenues (USD Million)
3. Market Share & Analysis
  1. By Therapy
  2. By Application
GCC Oncology/Cancer Drugs Industry- Market Attractiveness Indexing, 2018-2028F
GCC Oncology/Cancer Drugs Market Key Strategic Imperatives for Growth & Success
Competition Outlook
1. Competition Matrix
  1. Brand Specialization
  2. Target Markets
  3. Target End Users
  4. Research & Development
  5. Strategic Alliances
  6. Strategic Initiatives
2. Company Profiles
  1. Hoffmann-La Roche Ltd.
  2. Johnson & Johnson Middle East FZ LLC
  3. Pfizer International Corporation
  4. Merck Serono Middle East FZ-Ltd.
  5. AbbVie Biopharmaceuticals GmbH
  6. AstraZeneca Gulf FZ LLC
  7. Bayer Middle East FZE
  8. Amgen, Inc.
  9. Astellas MENA/SSA
  10. Others
Disclaimer

MarkNtel Advisors follows a robust and iterative research methodology designed to ensure maximum accuracy and minimize deviation in market estimates and forecasts. Our approach combines both bottom-up and top-down techniques to effectively segment and quantify various aspects of the market. A consistent feature across all our research reports is data triangulation, which examines the market from three distinct perspectives to validate findings. Key components of our research process include:

1. Scope & Research Design At the outset, MarkNtel Advisors define the research objectives and formulate pertinent questions. This phase involves determining the type of research—qualitative or quantitative—and designing a methodology that outlines data collection methods, target demographics, and analytical tools. They also establish timelines and budgets to ensure the research aligns with client goals.

2. Sample Selection and Data Collection In this stage, the firm identifies the target audience and determines the appropriate sample size to ensure representativeness. They employ various sampling methods, such as random or stratified sampling, based on the research objectives. Data collection is carried out using tools like surveys, interviews, and observations, ensuring the gathered data is reliable and relevant.

3. Data Analysis and Validation Once data is collected, MarkNtel Advisors undertake a rigorous analysis process. This includes cleaning the data to remove inconsistencies, employing statistical software for quantitative analysis, and thematic analysis for qualitative data. Validation steps are taken to ensure the accuracy and reliability of the findings, minimizing biases and errors.

4. Data Forecast and FinalizationThe final phase involves forecasting future market trends based on the analyzed data. MarkNtel Advisors utilize predictive modeling and time series analysis to anticipate market behaviors. The insights are then compiled into comprehensive reports, featuring visual aids like charts and graphs, and include strategic recommendations to inform client decision-making

Full Name*:

Company Name*:

Business Email*:

Country Name*:

Contact Number*:

Message:

Flexible Licensing Options

We offer flexible licensing options to cater to varying organizational needs. Choose the pricing pack that best suits your requirements:

Buy Now

Inquire Before Buying